OTHER GROUP COMPANIES
market

Board of Wockhardt approves acquisition of Wockhardt Biologics

Board of Wockhardt approves acquisition of Wockhardt Biologics

November 09, 2021 6:29 IST | capital market
The Board of Wockhardt at its meeting held on 09 November 2021 has approved the acquisition of remaining stake in Wockhardt Biologics (?WBL?) (CIN: U24299MH2021PLC363201) from the shareholders of WBL, making it a wholly owned subsidiary of the Company.

Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity